Abstract
CD44 isoforms serve as a marker for cancer stem cells. CD44 variant 9 (CD44v9) contributes to the defense against reactive oxygen species, resulting in resistance to chemoradiotherapy. However, the significance of CD44v9 in patients with lung adenocarcinoma is unknown. We used immunohistochemical analysis to retrospectively analyze CD44v9 expression in 268 surgically resected lung adenocarcinomas and investigated the association between CD44v9 expression and patients' clinicopathological features. The expression of CD44v9 in 193 of 268 (72.0%) patients was significantly associated with early-stage cancer, low-grade tumors, absence of vessel and pleural invasion, and a mutated epidermal growth factor receptor (EGFR) gene. Multivariate logistic analysis revealed that CD44v9 expression was significantly associated with early-stage disease [odds ratio (OR) 0.29, 95% confidence interval (CI) 0.14-0.59; p < 0.001] and mutant EGFR (OR 2.53, 95% CI 1.06-6.04; p = 0.036). The percentage of CD44v9-positive tumors was higher in the earlier stages of disease; however, there was no significant difference in the survival of patients in each stage of disease who had positive or negative CD44v9 expression. CD44v9 was highly expressed in EGFR-m...Continue Reading
References
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A YamaguchiK Furukawa
Oct 19, 2000·Oral Oncology·S SatoT Takata
Nov 2, 2001·Nature·T ReyaI L Weissman
Jan 4, 2003·Nature Reviews. Molecular Cell Biology·Helmut PontaPeter A Herrlich
Feb 6, 2009·Nature·Maximilian DiehnMichael F Clarke
Mar 11, 2011·Nature Reviews. Cancer·Margot Zöller
Mar 12, 2011·The Journal of Clinical Investigation·Rhonda L BrownChonghui Cheng
Mar 15, 2011·Cancer Cell·Takatsugu IshimotoHideyuki Saya
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey R OxnardPasi A Jänne
Jun 20, 2013·British Journal of Cancer·K HirataT Hibi
May 8, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mikihiro KohnoYoshihiko Maehara
Jul 1, 2014·Journal of Surgical Oncology·Naoki MashitaYasuhiro Kodera
Aug 22, 2014·The Journal of Biological Chemistry·Hiroki IshiiKeiji Miyazawa
Mar 10, 2015·PloS One·Takeichiro AsoMuneyuki Masuda
Mar 18, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Se-Il GoWoo Song Ha
Jun 3, 2016·PloS One·Amanda SosulskiDavid Pépin
Aug 9, 2016·The Journal of Clinical Investigation·Jill E LarsenJohn D Minna
Oct 26, 2016·Oncology Reports·Keita KobayashiKazuhiro Nagao
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
May 4, 2017·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kohei ShitaraAtsushi Ohtsu
Jul 2, 2017·Cancer Science·Kohei OtsuboIsamu Okamoto
Nov 8, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuko KawanoIsamu Okamoto
Nov 19, 2017·Immunology·Amy S CoddZsuzsanna Tabi
Nov 21, 2017·Clinical Lung Cancer·Kazuki TakadaYoshihiko Maehara
Jul 28, 2018·Molecular Cancer Therapeutics·Kenichi SudaFred R Hirsch